InHealth Technologies and Cytophil Inc. now global partners for the distribution of RENÚ® Voice and RENÚ® Transoral Needle
RENÚ® Voice offers a cost-effective treatment option for vocal fold insufficiency (VFI).* RENÚ® Voice has been proven substantially equivalent to other available injectable options and is CE marked and FDA-cleared for injectable vocal fold augmentation applications.
For more information, visit www.inhealth.com/renu.
If you would like to join us in the distribution of RENÚ® Voice and the RENÚ® Transoral Needle, please contact Bethany Anke at email@example.com.
*Data on file, InHealth Technologies.
RENÚ® Transoral Needle